Showing results (51-60 of 196) with videos related to
Sort By:
Pageof 20
Plos One|June 18, 2015
Rapid, Sensitive, and Accurate Evaluation of Drug Resistant Mutant (NS5A-Y93H) Strain Frequency in Genotype 1b HCV by Invader AssaySatoshi Yoshimi, Hidenori Ochi, Eisuke Murakami, et al.Liver Cancer|May 14, 2020
Skeletal Muscle Loss during Tyrosine Kinase Inhibitor Treatment for Advanced Hepatocellular Carcinoma PatientsShinsuke Uchikawa, Tomokazu Kawaoka, Maiko Namba, et al.Clinical Case Reports|November 21, 2018
Early experience of seven hepatocellular carcinoma cases treated with regorafenibShinsuke Uchikawa, Tomokazu Kawaoka, Hiroshi Aikata, et al.Scientific Reports|August 22, 2019
Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapyKazuki Ohya, Tomokazu Kawaoka, Maiko Namba, et al.Antiviral Chemistry & Chemotherapy|June 5, 2007
Mechanism of action of (-)-(2R,4R)-1-(2-hydroxymethyl-1,3-dioxolan-4-yl) thymine as an anti-HIV agentEisuke Murakami, Haiying Bao, Aravind Basavapathruni, et al.Oncology|August 15, 2012
Evaluation of the mRECIST and α-fetoprotein ratio for stratification of the prognosis of advanced-hepatocellular-carcinoma patients treated with sorafenibTomokazu Kawaoka, Hiroshi Aikata, Eisuke Murakami, et al.Antimicrobial Agents and Chemotherapy|November 15, 2006
Mechanism of activation of beta-D-2'-deoxy-2'-fluoro-2'-c-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymeraseEisuke Murakami, Haiying Bao, Mangala Ramesh, et al.International Journal of Molecular Sciences|October 29, 2025
Utility of Serum HBV RNA Measurement During Nucleoside/Nucleotide Analog Therapy in Chronic Hepatitis B PatientsKeiichi Hiraoka, Masataka Tsuge, Michihiko Kawahara, et al.Journal of Gastroenterology and Hepatology|August 30, 2014
Effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathwayYohji Honda, Shoichi Takahashi, Yizhou Zhang, et al.Journal of Gastroenterology|March 5, 2011
Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapyYuko Nagaoki, Hiroshi Aikata, Daisuke Miyaki, et al.Pageof 20